Your browser doesn't support javascript.
loading
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz, Steven; O'Connor, Owen A; Pro, Barbara; Illidge, Tim; Fanale, Michelle; Advani, Ranjana; Bartlett, Nancy L; Christensen, Jacob Haaber; Morschhauser, Franck; Domingo-Domenech, Eva; Rossi, Giuseppe; Kim, Won Seog; Feldman, Tatyana; Lennard, Anne; Belada, David; Illés, Árpád; Tobinai, Kensei; Tsukasaki, Kunihiro; Yeh, Su-Peng; Shustov, Andrei; Hüttmann, Andreas; Savage, Kerry J; Yuen, Sam; Iyer, Swaminathan; Zinzani, Pier Luigi; Hua, Zhaowei; Little, Meredith; Rao, Shangbang; Woolery, Joseph; Manley, Thomas; Trümper, Lorenz.
Afiliação
  • Horwitz S; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: horwitzs@mskcc.org.
  • O'Connor OA; Columbia University Medical Center, New York, NY, USA.
  • Pro B; Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Illidge T; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, National Institutes of Health and Research Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital National Health Service Foundation Trust, Manchester, UK.
  • Fanale M; MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Seattle Genetics, Inc, Bothell, WA, USA.
  • Advani R; Stanford Cancer Center, Blood and Marrow Transplant Program, Stanford, CA, USA.
  • Bartlett NL; Washington University School of Medicine, St Louis, MI, USA.
  • Christensen JH; Odense University Hospital, Odense, Denmark.
  • Morschhauser F; University of Lille, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.
  • Domingo-Domenech E; Institut Catala D'oncologia, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rossi G; Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy.
  • Kim WS; Samsung Medical Center, Seoul, South Korea.
  • Feldman T; Hackensack University Medical Center, Hackensack, NJ, USA.
  • Lennard A; Freeman Hospital, Newcastle upon Tyne, UK.
  • Belada D; 4th Department of Internal Medicine-Haematology, Charles University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic.
  • Illés Á; University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary.
  • Tobinai K; National Cancer Center Hospital, Tokyo, Japan.
  • Tsukasaki K; Saitama Medical University International Medical Center, Saitama, Japan.
  • Yeh SP; China Medical University Hospital, Taichung, Taiwan.
  • Shustov A; University of Washington Medical Center, Seattle, WA, USA.
  • Hüttmann A; Universitatsklinikum Essen, Essen, Nordrhein-Westfalen, Germany.
  • Savage KJ; University of British Columbia and the Department of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer, Vancouver, BC, Canada.
  • Yuen S; Calvary Mater Newcastle Hospital, Waratah, NSW, Australia.
  • Iyer S; MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
  • Zinzani PL; Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy.
  • Hua Z; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company.
  • Little M; Millennium Pharmaceuticals, Inc, Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company.
  • Rao S; Seattle Genetics, Inc, Bothell, WA, USA.
  • Woolery J; Seattle Genetics, Inc, Bothell, WA, USA.
  • Manley T; Seattle Genetics, Inc, Bothell, WA, USA.
  • Trümper L; Universitätsmedizin Göttingen, Göttingen, Germany.
Lancet ; 393(10168): 229-240, 2019 01 19.
Article em En | MEDLINE | ID: mdl-30522922
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes / Imunoconjugados / Fatores Imunológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Anaplásico de Células Grandes / Imunoconjugados / Fatores Imunológicos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article